Opioid Analgesic Recalled

Rhodes Pharmaceuticals is recalling a single lot of oxycodone hydrochloride tablets because a hydrochlorothiazide-lisinopril tablet was found in a bottle from the lot, according to the September 22, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 100-count bottles of oxycodone hydrochloride tablets, 10 mg (NDC 42858-002-01), from lot WP5K0Y (Exp. 2/28/23). That tablets were manufactured by Purdue Pharma, Stanford, CT, marketed by Rhodes Pharmaceuticals, Coventry, RI, and distributed throughout the United States.

Rhodes Pharmaceuticals voluntarily initiated the recall August 19, 2021. The FDA designated the recall Class II on September 13, 2021. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists.

Oxycodone hydrochloride is a prescription medication for the management of pain severe enough to require an opioid analgesic when alternative treatments are inadequate. Lisinopril-hydrochlorothiazide is a diuretic and antihypertensive drug prescribed for high blood pressure.